Image_2_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

“…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”

Image_3_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

“…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”

Image_6_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

“…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”

Table_2_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.docx by Casey E. Vantucci (10528263)

“…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”

Image_1_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

“…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”

PIV analysis of 2-cell stage embryos treated with DMSO or Latrunculin A. by Özge Özgüç (12290245)

Decreased myofibroblasts in the peritumoral region and high expression of MMP-7 in Pan02 S.C. tumor of <i>S100a4-Cre; Ext1</i>^<i>f/f</i> mice. by Ayumi Niwa (6256790)

“…<p>(A) Immunostaining of α-smooth muscle actin (αSMA)-positive spindle cells, i.e., myofibroblasts, in the peritumoral region of Pan02 S.C. pancreatic tumors in <i>S100a4-Cre; Ext1</i>^<i>f/f</i> and control mice (left). …”

Contents of chlorophyll a, chlorophyll b (Chl a, Chl b) and carotenoid in <i>D</i>. <i>parva</i> cells under treatment of various concentrations of MeJA and GA3. by Lingru Ruan (18995544)

Decrease of PrP^Res levels in ScN2a cells. by Natalia C. Ferreira (506057)

Probabilistic results of the incremental cost-effectiveness pairwise between various treatments with NVBP for a simulation of 100,000 iterations. by Yi Lin (49406)

3MC treatment of MCVECs increased the formation of AhR/c-Raf/pRb2/E2F1/HDAC1 complexes, with a concomitant decrease in E2F-driven luciferase activity. by Chih-Cheng Chang (540973)

GSK3 inhibition results in a decrease of p-β-Catenin. by Germán Cuesto (701284)

“…Only the treatment with 2 and 10 μM of AR-A014418 decreased p-β-Catenin levels. The co-treatment with the PI3K activator did not induce a further reduction. …”

Global suicide deaths by firearm, 1990–2019. by Irena Ilic (647686)

Suicide mortality by firearm in women, by countries: 10 highest/10 lowest rates in the world in 2019. by Irena Ilic (647686)

Suicide mortality by firearm in men, by countries: 10 highest / 10 lowest rates in the world in 2019. by Irena Ilic (647686)

Number of suicides by firearm (global and by WHO regions), by sexes, 2019. by Irena Ilic (647686)

Age-standardized mortality rates (global and by WHO regions) of suicide by firearm, by sexes, 2019. by Irena Ilic (647686)

Joinpoint regression analysis: Global trends^b'*' in age-specific mortality rates (per 100,000) of suicide by firearm, by sex, 1990–2019. by Irena Ilic (647686)

Pain duration dependent decrease in cognitive performance. by Marijtje L. A. Jongsma (208906)

“…The mean of the scores of the controls (with pain duration zero) on each of the nine tests was taken as 100%. For those test where an increase in test score indicated a decrease in performance, the inverse of the raw scores was taken. …”

IL-28A and IL-29 significantly decrease HCV replication. by Julia Diegelmann (107830)